U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: March 16 - 22, 2025
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: March 16 - 22, 2025

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Sara Brenner, M.D., M.P.H., Acting Commissioner for Food and Drugs

No Significant Event

Official Name: Kyle Diamantas, J.D., Acting Deputy Commissioner for Human Foods

Event Date: 03/21/2025
Location: College Park, MD
Subject: Introductory Meeting
FDA Participant/Group: ERIK METTLER; DONALD PRATER; CATHERINE MCDERMOTT; 
Non FDA Participant/Group: Richard Ball (New York State Department of Agriculture and Markets); Becky Garrison Warfel, Joe Reardon, Ted McKinney (National Association of State Departments of Agriculture);

Official Name: Ritu Nalubola, Ph.D., Acting Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Angelique Hebert, Acting Deputy Commissioner for Operations

No Significant Event

Official Name: Michael Rogers, Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Jacqueline Corrigan Curay, J.D., M.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 03/17/2025
Location: Virtual
Subject: 2025 Muscular Dystrophy Association Clinical and Scientific Conference; Panelist: Evolution of Neuromuscular Trials - Leveraging the Challenges and Successes of the Past to Forge a Promising Future
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, academia, healthcare, and patient advocate stakeholders

Event Date: 03/18/2025
Location: Virtual
Subject: Mucopolysaccharidosis Society (United Kingdom); Speaker: Facilitating Accelerated Approval
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, regulatory, and patient advocate stakeholders

Event Date: 03/20/2025
Location: Virtual
Subject: Duke Margolis Institute for Health Policy Virtual Convening; Panelist: Implementing Policies to Improve Evidence Generation
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, research, government, and health policy stakeholders

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 03/18/2025
Location: Washington, DC
Subject: Addressing the Impact of Tobacco and Alcohol Use on Cancer-Related Health Outcomes Workshop; Keynote Speaker: Addressing Modifiable Risk Factors Through Public Health Strategies: Lessons from Tobacco
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of the National Academies of Sciences, Engineering, and Medicine (NASEM), industry, academia, government, media, and other registered attendees

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Back to Top